These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29795405)

  • 1. Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment.
    Xiao P; Guo Y; Zhang H; Zhang X; Cheng H; Cao Q; Ke Y
    Oncogene; 2018 Sep; 37(37):5088-5100. PubMed ID: 29795405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.
    Liu W; Guo W; Shen L; Chen Z; Luo Q; Luo X; Feng G; Shu Y; Gu Y; Xu Q; Sun Y
    Oncotarget; 2017 Jan; 8(5):7586-7597. PubMed ID: 27935860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of PTEN causes SHP2 activation, making lung cancer cells unresponsive to IFN-γ.
    Chen CL; Chiang TH; Tseng PC; Wang YC; Lin CF
    Biochem Biophys Res Commun; 2015 Oct; 466(3):578-84. PubMed ID: 26385178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.
    Leibowitz MS; Srivastava RM; Andrade Filho PA; Egloff AM; Wang L; Seethala RR; Ferrone S; Ferris RL
    Clin Cancer Res; 2013 Feb; 19(4):798-808. PubMed ID: 23363816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment.
    Quintana E; Schulze CJ; Myers DR; Choy TJ; Mordec K; Wildes D; Shifrin NT; Belwafa A; Koltun ES; Gill AL; Singh M; Kelsey S; Goldsmith MA; Nichols R; Smith JAM
    Cancer Res; 2020 Jul; 80(13):2889-2902. PubMed ID: 32350067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer.
    Tseng PC; Huang WC; Chen CL; Sheu BS; Shan YS; Tsai CC; Wang CY; Chen SO; Hsieh CY; Lin CF
    Immunobiology; 2012 Sep; 217(9):926-34. PubMed ID: 22325465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
    Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
    Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells.
    Thakur A; Schalk D; Sarkar SH; Al-Khadimi Z; Sarkar FH; Lum LG
    Cancer Immunol Immunother; 2012 Apr; 61(4):497-509. PubMed ID: 21971587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells.
    Tseng PC; Chen CL; Shan YS; Lin CF
    Oncotarget; 2016 Mar; 7(12):15150-60. PubMed ID: 26934444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous tumors cease CXCL9/Mig production as a result of IFN-γ-mediated immunoediting.
    Petro M; Kish D; Guryanova OA; Ilyinskaya G; Kondratova A; Fairchild RL; Gorbachev AV
    J Immunol; 2013 Jan; 190(2):832-41. PubMed ID: 23241877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-γ expression in the neoplastic cells and macrophages of Hodgkin lymphoma: clinicopathologic correlations and potential prognostic implications.
    P Vassilakopoulos T; Levidou G; Milionis V; Hartmann S; Lakiotaki E; Sepsa A; Thymara I; Ntailiani P; Spanou K; K Angelopoulou M; P Siakantaris M; Moschogiannis M; A Pangalis G; Panayiotidis P; Konstantopoulos K; Patsouris E; Hansmann ML; Korkolopoulou P
    Leuk Lymphoma; 2017 Sep; 58(9):1-13. PubMed ID: 28571489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma.
    Lengagne R; Pommier A; Caron J; Douguet L; Garcette M; Kato M; Avril MF; Abastado JP; Bercovici N; Lucas B; Prévost-Blondel A
    PLoS One; 2011; 6(5):e20235. PubMed ID: 21633700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
    Clancy-Thompson E; Perekslis TJ; Croteau W; Alexander MP; Chabanet TB; Turk MJ; Huang YH; Mullins DW
    Cancer Immunol Res; 2015 Aug; 3(8):956-67. PubMed ID: 26048575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori infection activates Src homology-2 domain-containing phosphatase 2 to suppress IFN-γ signaling.
    Wang YC; Chen CL; Sheu BS; Yang YJ; Tseng PC; Hsieh CY; Lin CF
    J Immunol; 2014 Oct; 193(8):4149-58. PubMed ID: 25225672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-Restricted Shp2 Tyrosine Phosphatase Acts as a Rheostat for MMP12 through TGF-β Activation in the Prevention of Age-Related Emphysema in Mice.
    Xu J; Tao B; Guo X; Zhou S; Li Y; Zhang Y; Zhou Z; Cheng H; Zhang X; Ke Y
    J Immunol; 2017 Oct; 199(7):2323-2332. PubMed ID: 28814604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment.
    Zhang QQ; Hu XW; Liu YL; Ye ZJ; Gui YH; Zhou DL; Qi CL; He XD; Wang H; Wang LJ
    Sci Rep; 2015 Nov; 5():15948. PubMed ID: 26526388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.
    Mauldin IS; Wages NA; Stowman AM; Wang E; Smolkin ME; Olson WC; Deacon DH; Smith KT; Galeassi NV; Chianese-Bullock KA; Dengel LT; Marincola FM; Petroni GR; Mullins DW; Slingluff CL
    Cancer Immunol Immunother; 2016 Oct; 65(10):1189-99. PubMed ID: 27522581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of natural killer cells in advanced stages of endogenously arising B-cell lymphoma: implications for therapeutic cell transfer.
    Przewoznik M; Hömberg N; Naujoks M; Pötzl J; Münchmeier N; Brenner CD; Anz D; Bourquin C; Nelson PJ; Röcken M; Mocikat R
    J Immunother; 2012 Apr; 35(3):217-22. PubMed ID: 22421939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting SHP2 as a promising strategy for cancer immunotherapy.
    Liu Q; Qu J; Zhao M; Xu Q; Sun Y
    Pharmacol Res; 2020 Feb; 152():104595. PubMed ID: 31838080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.